# OnCo record proda-biotech (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/proda-biotech/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "proda-biotech" ;
  schema:name "ProDa BioTech"@en ;
  schema:alternateName "ProDa BioTech, LLC"@en, "PRODA BIOTECH, LLC"@en ;
  schema:description "ProDa BioTech is a company in Marietta, Georgia, developing ProAgio, a protein drug that kills cells carrying an integrin receptor in tumours and the tissue around them. ProAgio is in an early trial with chemotherapy in triple-negative breast cancer that has spread."@en ;
  schema:url <https://onco.cc/companies/proda-biotech/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://reporter.nih.gov/project-details/11409793>, <https://clinicaltrials.gov/search?lead=ProDa%20BioTech> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/tnbc/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/proagio/> ;
  onco:trials <https://onco.cc/trials/nct06460298/> .